Therapy for Sale: The Fragile Safety Net for Vulnerable Families and How Fraud is Breaking It

State-funded therapy programs, designed to assist children with autism and other developmental needs, have become fertile ground for large-scale fraud. Reports of fabricated patient records and inflated claims highlight systemic oversight failures across multiple states, draining billions from vulnerable families and taxpayers. This crisis underscores the broader risks of expanded healthcare programs launched without adequate safeguards.

Children need help, families need answers, and money needs to move. That’s the core promise of state-funded therapy programs for autism and developmental disorders—programs that offer vital services many families could not otherwise afford. But in too many cases, that promise is breaking. Across states like Minnesota, Massachusetts, Idaho, and California, reports of fraud are surfacing at staggering scale. Providers have submitted claims for fake therapy sessions, enrolled families under false pretenses, and in some cases used unqualified staff for highly specialized treatments. The result is billions drained from Medicaid budgets, leaving taxpayers on the hook and vulnerable families underserved.

In Minnesota, a U.S. Attorney quantified the depth of this problem in just one state: more than half of $18 billion billed to high-risk Medicaid programs since 2018 may be fraudulent, amounting to $9 billion in stolen taxpayer funds. “The fraud is not small. It isn’t isolated. The magnitude cannot be overstated,” said Assistant U.S. Attorney Joe Thompson during a press conference in December 2025. Minnesota’s Early Intensive Development and Behavior Intervention (EIDBI) program, aimed at providing therapy to children with autism, has been among the hardest-hit. Recent federal cases revealed schemes involving fabricated patient records, unqualified therapy providers, and claims for hours of therapy that never occurred.

The issue isn’t confined to Minnesota. In Massachusetts, fraudulent billing for behavioral therapy is widespread. Patrice Lamour, owner of two Randolph-based health companies, was indicted in 2025 for billing more than $1 million to Medicaid for unprovided therapy services. The Massachusetts Inspector General revealed up to $17.3 million in overpayments linked to autism therapy as a result of lax oversight and poor credentialing verification. In some cases, fake documentation suggested supervisory sessions by licensed behavioral analysts who were rarely or never on site.

The patterns of fraud are shockingly similar across states, raising a critical question: Are these isolated incidents, or do they reveal a deeper design flaw in how these programs are structured and monitored?

At their core, these therapy programs were born out of urgent necessity. Federal Medicaid expansions and state mandates requiring autism treatment coverage have grown the program pool dramatically in the past decade. Advocates celebrated these expansions as lifelines, enabling parents of children with autism and developmental challenges to access therapies that can cost tens of thousands of dollars annually. But oversight systems failed to match the pace of this growth.

The problem begins with how these payments work. Providers are reimbursed per service or hour of therapy delivered, making these programs vulnerable to exploitation through dishonest documentation and billing manipulation. Without rigorous pre-payment reviews or advanced fraud detection, fraudulent claims often sail through unchecked. In Minnesota, oversight gaps were so severe that out-of-state actors figured out how to exploit local programs remotely. Two men based in Philadelphia, for instance, set up a fraud scheme in Minnesota’s Housing Stabilization Services program, collecting $3.5 million by submitting fake claims for care they never delivered.

In Idaho, concerns over billing abuses led to a sweeping policy shift. In December 2025, Idaho became the first state to remove Medicaid funding for Applied Behavioral Analysis (ABA)—a common therapy for children with autism—through its managed care organization. Citing fraud risks and administrative inefficiency, the state moved autism therapy into Children’s Habilitation Intervention Services, a state-managed program with tighter controls on billing and supervision. While the change reflects Idaho’s deep concerns about fraud, families reported disruptions to their children’s care and added confusion over the new administrative process.

The fallout from these fraud cases ripples out to harm society’s most vulnerable: families who unknowingly enroll in programs that fail to deliver promised care. The systemic issues are clear. Medicaid-funded therapy programs often fall into a regulatory gray zone between healthcare, education, and social services, leaving no single agency fully responsible for monitoring. Audits are rare; credentialing requirements are poorly enforced; and programs often lack data analytics to spot billing anomalies. These shortcomings, compounded by the rapid expansion of new therapy mandates, have created what some experts call “fraud tourism.” Criminal actors move interstate to exploit lightly monitored programs like Minnesota’s, siphoning millions in taxpayer funds while legitimate needs go unmet.

The stakes extend beyond wasted dollars. For children with autism who rely on evidence-based interventions, delays or disruptions in care can worsen long-term outcomes. Families assume they’re getting therapy, but fraudulent providers often deliver little to nothing. Meanwhile, trust in these programs erodes among lawmakers, taxpayers, and the public. In Minnesota, the fraud uncovered by federal authorities caught even state officials off guard. State agencies were forced to suspend payments to multiple providers and shut down programs outright after credible fraud allegations surfaced.

The broader social consequences of such failures cannot be ignored. Publicly funded therapy programs represent both a financial and moral commitment to supporting children with disabilities and developmental challenges. Their success stories provide a roadmap for how society can ensure greater equity in healthcare access. But when systemic flaws go unaddressed, those stories are overshadowed by fraud, scandal, and diverted resources.

The failure here is twofold: structural and cultural. Structurally, programs lacked the preemptive safeguards necessary to deter fraudulent actors. Culturally, the pressure to expand coverage often resulted in shortcuts that left programs profoundly vulnerable. Fixing this will not be easy, but it is critical. States may need to adopt stricter pre-payment processes, deploy data-driven fraud analytics, and standardize compliance reviews across jurisdictions.

For now, families are left navigating broken systems, wondering whether they can trust the care providers they desperately need. Taxpayers, meanwhile, bear the costs—not just in diverted funds but also in eroded confidence in public institutions’ ability to deliver.

The question going forward is not merely how fraud like this can be stopped. It’s whether public therapy programs, conceived as a lifeline for the most vulnerable, can fulfill their promise without succumbing to their own inherent weaknesses.